Arnado, Jenevive .

HRN: 22-45-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
CEFTRIAXONE 1G (VIAL)
12/15/2023
12/22/2023
IVT
2 Gm
Q 24h
Acute Pyelonephritis; G4P3 (3003)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: